Clinical Study
Prevalence of Occult Hepatitis C Virus in Egyptian Patients with Chronic Lymphoproliferative Disorders
Table 3
Correlation between clinical and laboratory data in HCV positive and OCI positive LPD patients versus HCV and OCI negative LPD patients.
| Parameter | LPD patients | HCV positive | OCI positive | HCV and OCI negative | | value | | value | | value |
| Age | 0.091 | 0.528 | 0.082 | 0.571 | 0.018 | 0.9 | Hepatomegaly | 0.060 | 0.267 | 0.063 | 0.257 | 0.161 | 0.244 | Splenomegaly | 0.092 | 0.526 | 0.089 | 0.538 | 0.095 | 0.514 | Sex | 0.022 | 0.399 | 0.096 | 0.172 | 0.0171 | 0.234 | Hb (gm%) | 0.323 | 0.037 | 0.086 | 0.552 | 0.092 | 0.525 | Platelets mm³ | 0.437 | 0.040 | 0.316 | 0.013 | 0.065 | 0.653 | TLC/mm³ | 0.074 | 0.608 | 0.018 | 0.413 | 0.000 | 0.999 | AST | 0.022 | 0.398 | 0.446 | 0.053 | 0.048 | 0.742 | ALT | 0.221 | 0.044 | 0.029 | 0.110 | 0.250 | 0.08 | Bilirubin (T) | 0.059 | 0.682 | 0.518 | 0.021 | 0.236 | 0.098 |
|
|